Inventor

Philip A. Carpino

Inventor

Groton, CT, US

Overview

1998–2018

Patent span

Human necessities

Primary field (CPC A)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds31%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%

A61KPreparations for medical, dental or toiletry purposes18%

C07KPeptides14%

G01NInvestigating or analysing materials by determining their chemical or physical properties4%

Y02PClimate change mitigation technologies in the production or processing of goods4%

C07CAcyclic or carbocyclic compounds1%

PatentTitleYear

9,873,6732-thiopyrimidinones2018 9,399,626'2-thiopyrimidinones'2016 9,296,745'Diacylglycerol acyltransferase 2 inhibitors'2016 7,354,929'Cannabinoid receptor ligands and uses thereof'2008 7,241,788'Cannabinoid receptor ligands and uses thereof'2007 7,232,823'Cannabinoid receptor ligands and uses thereof'2007 7,230,024'Cannabinoid receptor ligands and uses thereof'2007 7,151,097'Bicyclic pyrazolyl and imidazolyl compounds and uses thereof'2006 7,145,012'Cannabinoid receptor ligands and uses thereof'2006 7,141,669'Cannabiniod receptor ligands and uses thereof'2006 7,074,929'Certain alkylene diamine-substituted heterocycles'2006 6,953,791'Dipeptide derivatives'2005 6,951,850'Dipeptide derivatives'2005 6,924,280'Dipeptide derivatives'2005 6,867,202'Treatment of insulin resistance'2005 RE038524'Dipeptide derivatives as growth hormone secretagogues'2004 6,696,445'Certain alkylene diamine-substituted heterocycles'2004 6,686,359'Growth hormone secretagogues'2004 6,630,487'Treatment of insulin resistance with growth hormone secretagogues'2003 6,596,867'Tartrate salt of a substituted dipeptide as growth hormone secretagogue'2003 6,559,150'Growth hormone secretagogues'2003 6,525,047'Dipeptide derivatives'2003 6,506,762'Certain alkylene diamine-substituted heterocycles'2003 6,482,825'Growth-hormone secretagogues'2002 6,476,038'Amino substituted pyrazolo1,5,-a-1,5-pyrimidines and pyrazolo1,5-a-1,3,5-triazines'2002 6,448,263'Treatment of insulin resistance with growth hormone secretagogues'2002 6,433,171'Dipeptide derivatives'2002 6,432,945'Dipeptide derivatives'2002 6,429,313'Dipeptide derivatives'2002 6,407,120'Neuropeptide Y antagonists'2002 6,372,743'Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines'2002 6,358,951'Growth hormone secretagogues'2002 6,337,332'Neuropeptide Y receptor antagonists'2002 6,313,140'Method of treatment using certain growth-hormone secret agogues'2001 6,306,875'Growth-hormone secretagogues'2001 6,278,000'Growth-hormone secretagogues'2001 6,251,902'Dipeptide derivatives as growth hormone secretagogues'2001 6,248,717'Tartrate salt of a substituted dipeptide as growth hormone secretagogue'2001 6,124,264'Heterocyclic compounds'2000 6,110,932'Growth hormone secretagogues'2000 6,107,306'Heterocyclic compounds'2000 5,936,089'Dipeptides which promote release of growth hormone'1999 5,789,415'Azacyclic-heterocyclic compounds as angiotension II receptor antagonists'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2018Patents assigned to PFIZER (43)· patent assignee history

1998–2008Based in Groton, CT, US· patent location history

2002–2004Patents assigned to NEUROGEN CORP (4)· patent assignee history

2016–2018Based in Newton, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PFIZER	43	1998–2018
NEUROGEN CORP	4	2002–2004

Locations

Location	Patents	Span
Groton, CT, US	40	1998–2008
Newton, Massachusetts, US	3	2016–2018